Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
1.270
+0.140 (12.39%)
Aug 22, 2025, 4:00 PM - Market closed
Rein Therapeutics Market Cap
Rein Therapeutics has a market cap or net worth of $29.60 million as of August 22, 2025. Its market cap has decreased by -43.30% in one year.
Market Cap
29.60M
Enterprise Value
23.88M
1-Year Change
-43.30%
Ranking
Category
Stock Price
$1.27
Market Cap Chart
Since June 29, 2017, Rein Therapeutics's market cap has decreased from $158.90M to $29.60M, a decrease of -81.37%. That is a compound annual growth rate of -18.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 26.30M | -47.19% |
| Dec 31, 2024 | 49.80M | 260.87% |
| Dec 29, 2023 | 13.80M | 27.78% |
| Dec 30, 2022 | 10.80M | -78.82% |
| Dec 31, 2021 | 51.00M | 20.57% |
| Dec 31, 2020 | 42.30M | 166.04% |
| Dec 31, 2019 | 15.90M | 28.23% |
| Dec 31, 2018 | 12.40M | -92.01% |
| Dec 29, 2017 | 155.10M | -2.39% |
| Jun 29, 2017 | 158.90M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 640.53B |
| Johnson & Johnson | 431.53B |
| AbbVie | 369.79B |
| UnitedHealth Group | 278.22B |
| AstraZeneca | 250.88B |
| Novartis AG | 246.51B |
| Novo Nordisk | 246.31B |
| Abbott Laboratories | 230.23B |